Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myomo (MYO) EBT (2017 - 2025)

Myomo filings provide 9 years of EBT readings, the most recent being -$3.5 million for Q3 2025.

  • On a quarterly basis, EBT fell 300.13% to -$3.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.7 million, a 41.61% increase, with the full-year FY2024 number at $1.0 million, up 112.6% from a year prior.
  • EBT hit -$3.5 million in Q3 2025 for Myomo, up from -$4.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $6.6 million in Q4 2024 to a low of -$4.5 million in Q2 2025.
  • Median EBT over the past 5 years was -$2.6 million (2021), compared with a mean of -$2.1 million.
  • Biggest five-year swings in EBT: soared 378.3% in 2024 and later plummeted 344.9% in 2025.
  • Myomo's EBT stood at -$2.9 million in 2021, then grew by 18.85% to -$2.4 million in 2022, then dropped by 0.75% to -$2.4 million in 2023, then skyrocketed by 378.3% to $6.6 million in 2024, then tumbled by 153.05% to -$3.5 million in 2025.
  • The last three reported values for EBT were -$3.5 million (Q3 2025), -$4.5 million (Q2 2025), and -$3.3 million (Q1 2025) per Business Quant data.